| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/15/2010 | WO2009134420A3 Epigenetic silencing of tumor suppressor genes |
| 04/15/2010 | WO2009129549A3 Babesia microti genomic clones containing novel antigens useful in the diagnosis of babesiosis |
| 04/15/2010 | WO2009104001A3 Oligopeptidic compounds and uses thereof |
| 04/15/2010 | WO2009095925A3 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 04/15/2010 | WO2005074981A8 Inhibitors of tgf-r signaling for treatment of cns disorders |
| 04/15/2010 | US20100095399 Protein for use in modifying abiotic stress tolerance in yeast |
| 04/15/2010 | US20100095398 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 04/15/2010 | US20100095397 Polynucleotides and methods for the improvement of plants |
| 04/15/2010 | US20100095390 Aldolases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 04/15/2010 | US20100093988 Nucleic acid encoding receptor type protein kinase |
| 04/15/2010 | US20100093978 Dkk-related proteins |
| 04/15/2010 | US20100093976 Use of interleukin-11 as therapeutic agent for heart disease |
| 04/15/2010 | US20100093934 Pegylation of recombinant blood coagulation factors in the presence of bound antibodies |
| 04/15/2010 | US20100093933 Substituted Guar Protein Extracts and Production/Applications Thereof |
| 04/15/2010 | US20100093838 Regulation of angiogenesis with zinc finger proteins |
| 04/15/2010 | US20100093831 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 04/15/2010 | US20100093642 Novel polypeptides |
| 04/15/2010 | US20100093636 Methods of treating inflammation |
| 04/15/2010 | US20100093633 Polypeptides having antimicrobial activity |
| 04/15/2010 | US20100093630 Mammalian chemokines; related reagents |
| 04/15/2010 | US20100093629 Genes and polypeptides relating to human pancreatic cancers |
| 04/15/2010 | US20100093628 Methods of treatment using wisp polypeptides |
| 04/15/2010 | US20100093627 Albumin fusion proteins |
| 04/15/2010 | US20100093625 Smoothened polypeptides and methods of use |
| 04/15/2010 | US20100093624 Peptide therapeutics that bind vegf and methods of use thereof |
| 04/15/2010 | US20100093623 Compositions and methods for modulating nod-like receptor activity and uses thereof |
| 04/15/2010 | US20100093620 Tyrosine-rich conopeptides |
| 04/15/2010 | US20100093618 Polypeptide capable of inhibiting hiv-1 transcription and replication and uses thereof |
| 04/15/2010 | US20100093617 Use |
| 04/15/2010 | US20100093608 Modified animal erythropoietin polypeptides and their uses |
| 04/15/2010 | US20100093604 Gpr43 and modulators thereof for the treatment of metabolic-related disorders |
| 04/15/2010 | US20100093600 Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions |
| 04/15/2010 | US20100093056 Antibodies that bind dkk-related proteins |
| 04/15/2010 | US20100093030 Production of secreted proteins by filamentous fungi |
| 04/15/2010 | US20100093029 Modified luciola cruciata luciferase gene and protein |
| 04/15/2010 | US20100093028 Modified variant bowman birk protease inhibitors |
| 04/15/2010 | US20100092990 Nucleic acids encoding sodium channel scn1a alpha subunit proteins and mutations associated with epilepsy |
| 04/15/2010 | US20100092975 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer |
| 04/15/2010 | US20100092941 32142,21481,25964,21686, Novel dehydrogenase molecules and uses therefor |
| 04/15/2010 | US20100092940 Method and Device for Detecting Feline Immunodeficiency Virus |
| 04/15/2010 | US20100092778 Method for producing particles and particles |
| 04/15/2010 | US20100092640 UTILIZATION OF FATTY ACID DESATURASES FROM Hemiselmis spp. |
| 04/15/2010 | US20100092539 Fluorinated GHRH Antagonists |
| 04/15/2010 | US20100092538 Nucleic Acids Encoding Spider Glue Proteins and Methods of Use Thereof |
| 04/15/2010 | US20100092522 Immunogenic wt-1 peptides and methods of use thereof |
| 04/15/2010 | US20100092520 Recombinant Plasmodium Falciparum Merozoite Surface Proteins 4 and 5 and Their Use |
| 04/15/2010 | US20100092513 Methods and compositions for inducing an immune response to HIV and models for testing |
| 04/15/2010 | US20100092509 Hypo- and Hyper- Acetylated Meningococcal Capsular Saccharides |
| 04/15/2010 | US20100092508 Molecular Antigen Arrays |
| 04/15/2010 | US20100092503 Hcv fusion polypeptideds |
| 04/15/2010 | US20100092502 Modified hiv env polypeptides |
| 04/15/2010 | US20100092501 Foxp3 peptide vaccine |
| 04/15/2010 | US20100092500 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes |
| 04/15/2010 | US20100092492 Vascular endothelial cell growth factor antagonists |
| 04/15/2010 | US20100092477 Methods and compositions for treating prostate cancer |
| 04/15/2010 | US20100092458 Regulation of apg8 phosphorylation and uses thereof |
| 04/15/2010 | US20100092435 Use of a varicellovirus tap-inhibitor for the induction of tumor-or virus-specific immunity against teipp |
| 04/15/2010 | US20100092431 Edwardsiella Ictaluri Bacteriophage and Uses Thereof |
| 04/15/2010 | US20100092409 that target cytokines; greater activity; produced at greater yields; second protease inhibitory loop of BBPI scaffold is replaced with a binding peptide: VEGF binding peptide, fibroblast growth factor-5 (FGF) binding peptide, transforming growth factor beta (TGF) binding peptide, or TNF binding protein |
| 04/15/2010 | US20100092386 System for delivering therapeutic agents into living cells and cells nuclei |
| 04/15/2010 | DE102008051574A1 Method for extracting a protein with interferon-beta-activity, comprises culturing cells with the ability to synthesize the protein in a culture medium containing a block copolymer of ethylene oxide and propylene oxide |
| 04/15/2010 | DE102004044419B4 Verfahren zur Aufreinigung eines von Willebrand Faktors mittels Hydroxylapatit-Durchlaufchromatographie Process for the purification of von Willebrand factor by hydroxyapatite-flow chromatography |
| 04/15/2010 | CA2743361A1 Methods and systems for predicting misfolded protein epitopes |
| 04/15/2010 | CA2740079A1 Methods of making concentrated fibrinogen- and platelet-containing compositions |
| 04/15/2010 | CA2740046A1 Detection of granulosa-cell tumors |
| 04/15/2010 | CA2739971A1 Il-17-mediated transfection methods |
| 04/15/2010 | CA2739867A1 Estrogen and anti-estrogen marker genes |
| 04/15/2010 | CA2739679A1 Modulation of the activity and differentiation of cells expressing the osteoclast-associated receptor |
| 04/15/2010 | CA2739615A1 Fgf21 mutants and uses thereof |
| 04/15/2010 | CA2739608A1 Recombinant nell protein production |
| 04/15/2010 | CA2739532A1 Method for determining drug resistance mutations in any of the non-structural protein regions ns3 to ns5b of hepatitis c virus (hcv) for genotypes 1 to 6 |
| 04/15/2010 | CA2739122A1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 04/15/2010 | CA2739111A1 Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease |
| 04/15/2010 | CA2738983A1 Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides |
| 04/15/2010 | CA2737924A1 Methods of treating inflammation |
| 04/15/2010 | CA2737259A1 Epitopes derived from satb2 and uses thereof |
| 04/14/2010 | EP2175270A1 Method of screening inhibitor by using induction of interleukin 18 production by keratinocyte, method of inducing atopic dermatitis-like symptom and utilization of the same |
| 04/14/2010 | EP2175028A2 Phosphatase stress-related proteins and methods of use in plants |
| 04/14/2010 | EP2175022A1 Methods of construction biodiverse gene fragment libraries |
| 04/14/2010 | EP2175017A1 Pseudomonas aeruginosa outer membrane protein pa4710 |
| 04/14/2010 | EP2174957A1 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 04/14/2010 | EP2174956A1 Compositions for anti-fibrinolitic treatment |
| 04/14/2010 | EP2174955A1 Ifnar2 muteins, their production and use |
| 04/14/2010 | EP2174954A1 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 04/14/2010 | EP2174953A1 Compositions and methods for the diagnosis and treatment of tumor |
| 04/14/2010 | EP2174952A2 glp-1 (glucagon-like peptide-1) fusion polypeptides with increased peptidase resistance |
| 04/14/2010 | EP2174951A2 Mutant of granulocyte-colony stimulating factor (G-CSF) and chemically conjugated polypeptide thereof |
| 04/14/2010 | EP2174950A1 fermentation process for the production of diphtheria toxin |
| 04/14/2010 | EP2174949A2 Leucine-based motif and clostridial neurotoxins |
| 04/14/2010 | EP2174948A1 Antiviral polypeptides |
| 04/14/2010 | EP2174946A1 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 04/14/2010 | EP2174674A1 Methods and compositions for healing and repair of articular cartilage |
| 04/14/2010 | EP2174668A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 04/14/2010 | EP2174663A1 Stabilized aqueous compositions comprising tissue factor pathway inhibitor (TFPI) or tissue factor pathway inhibitor variant |
| 04/14/2010 | EP2174142A2 Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications |
| 04/14/2010 | EP2174130A2 Copolymer assay |
| 04/14/2010 | EP2173902A1 Therapeutics and diagnostics for group a streptococci |
| 04/14/2010 | EP2173890A1 Biological active proteins having increased in vivo and/or vitro stability |
| 04/14/2010 | EP2173885A2 Expression cassette, t-dna molecule, plant expression vector, transgenic plant cell as well as their use in the manufacturing of a vaccine |
| 04/14/2010 | EP2173884A2 Plants having increased yield-related traits and a method for making the same |